MSI analysis update
================

Table S1. Clinicopathological and molecular features by exclusion status
------------------------------------------------------------------------

-   Included patients had a higher proportion of rectal cancer
-   Excluded patients had slightly more proximal and distal
-   A larger proportion of excluded patients came from 1991-2000 decade of diagnosis
    (follow up months should differ because missing or incomplete f/u is a condition for exclusion)

<head>
<style>
        table, th, td {
        border: 1px solid #bcbcbc;
    } </style>
</head>
<table cellpadding="10" cellspacing="5">
<caption>
Descriptive Statistics by 'final\_exclude'
</caption>
<tr>
<th>
final\_exclude
</th>
<th>
exclude<br/>(N=130)
</th>
<th>
included<br/>(N=518)
</th>
<th>
p
</th>
</tr>
<tr>
<td>
Race\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.086
</td>
</tr>
<tr>
<td>
    Black
</td>
<td>
50 (38.5%)
</td>
<td>
225 (43.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Other
</td>
<td>
1 ( 0.8%)
</td>
<td>
0 ( 0.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    White
</td>
<td>
79 (60.8%)
</td>
<td>
293 (56.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
AGE\_MB
</td>
<td>
</td>
<td>
</td>
<td>
1.000
</td>
</tr>
<tr>
<td>
    ? 65
</td>
<td>
66 (50.8%)
</td>
<td>
265 (51.2%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    &lt; 65
</td>
<td>
64 (49.2%)
</td>
<td>
253 (48.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Sex\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.461
</td>
</tr>
<tr>
<td>
    F
</td>
<td>
61 (46.9%)
</td>
<td>
222 (42.9%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    M
</td>
<td>
69 (53.1%)
</td>
<td>
296 (57.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Location\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.026
</td>
</tr>
<tr>
<td>
    Rectum
</td>
<td>
13 (10.0%)
</td>
<td>
103 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Distal
</td>
<td>
52 (40.0%)
</td>
<td>
172 (33.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Proximal
</td>
<td>
65 (50.0%)
</td>
<td>
240 (46.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
T\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.517
</td>
</tr>
<tr>
<td>
    pT1
</td>
<td>
17 (13.3%)
</td>
<td>
57 (11.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT2
</td>
<td>
53 (41.4%)
</td>
<td>
202 (39.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT3
</td>
<td>
39 (30.5%)
</td>
<td>
191 (37.2%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT4
</td>
<td>
19 (14.8%)
</td>
<td>
64 (12.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
N\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.365
</td>
</tr>
<tr>
<td>
    N0
</td>
<td>
82 (63.6%)
</td>
<td>
297 (58.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    N1-2
</td>
<td>
47 (36.4%)
</td>
<td>
209 (41.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
M\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.977
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
112 (86.8%)
</td>
<td>
444 (87.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
17 (13.2%)
</td>
<td>
64 (12.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
AJCC.stage
</td>
<td>
</td>
<td>
</td>
<td>
0.768
</td>
</tr>
<tr>
<td>
    I
</td>
<td>
17 (13.3%)
</td>
<td>
57 (11.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    II
</td>
<td>
54 (42.2%)
</td>
<td>
210 (40.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    III
</td>
<td>
40 (31.2%)
</td>
<td>
184 (35.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    IV
</td>
<td>
17 (13.3%)
</td>
<td>
64 (12.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
p53mutated
</td>
<td>
</td>
<td>
</td>
<td>
0.150
</td>
</tr>
<tr>
<td>
    Wt
</td>
<td>
37 (52.1%)
</td>
<td>
219 (42.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    mutated
</td>
<td>
34 (47.9%)
</td>
<td>
299 (57.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
MSI\_Status\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.093
</td>
</tr>
<tr>
<td>
    MSS
</td>
<td>
88 (67.7%)
</td>
<td>
334 (64.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    MSI-H
</td>
<td>
22 (16.9%)
</td>
<td>
128 (24.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    MSI-L
</td>
<td>
20 (15.4%)
</td>
<td>
56 (10.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
decade
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    1981-1990
</td>
<td>
24 (18.5%)
</td>
<td>
183 (35.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1991-2000
</td>
<td>
77 (59.2%)
</td>
<td>
182 (35.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    2001-2007
</td>
<td>
29 (22.3%)
</td>
<td>
153 (29.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
event
</td>
<td>
</td>
<td>
</td>
<td>
0.976
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
66 (61.7%)
</td>
<td>
322 (62.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
41 (38.3%)
</td>
<td>
194 (37.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Survival\_V
</td>
<td>
-111.3 ± 426.7
</td>
<td>
66.7 ± 63.9
</td>
<td>
0.000
</td>
</tr>
</table>
Table 1. Clinicopathological and molecular features by race
-----------------------------------------------------------

<table style="width:100%;">
<colgroup>
<col width="7%" />
<col width="69%" />
<col width="23%" />
</colgroup>
<thead>
<tr class="header">
<th>Race</th>
<th>Higher proportion</th>
<th>Lower proportion</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Blacks</td>
<td>Women, proximal, early or mid stages,MSI-L, decade dx <em>recent</em></td>
<td>Deaths from cancer, rectal cancers</td>
</tr>
<tr class="even">
<td>Whites</td>
<td>Men, stages IV and I, MSS, decade dx <em>oldest</em>, deaths from cancer</td>
<td>MSI-H &amp; MSI-L</td>
</tr>
</tbody>
</table>

<head>
<style>
        table, th, td {
        border: 1px solid #bcbcbc;
    } </style>
</head>
<table cellpadding="10" cellspacing="5">
<caption>
Descriptive Statistics by 'Race\_V'
</caption>
<tr>
<th>
Race\_V
</th>
<th>
Black<br/>(N=225)
</th>
<th>
White<br/>(N=293)
</th>
<th>
p
</th>
</tr>
<tr>
<td>
AGE\_MB
</td>
<td>
</td>
<td>
</td>
<td>
1.000
</td>
</tr>
<tr>
<td>
    ? 65
</td>
<td>
115 (51.1%)
</td>
<td>
150 (51.2%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    &lt; 65
</td>
<td>
110 (48.9%)
</td>
<td>
143 (48.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Sex\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    F
</td>
<td>
121 (53.8%)
</td>
<td>
101 (34.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    M
</td>
<td>
104 (46.2%)
</td>
<td>
192 (65.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Location\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    Rectum
</td>
<td>
24 (10.7%)
</td>
<td>
79 (27.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Distal
</td>
<td>
77 (34.4%)
</td>
<td>
95 (32.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Proximal
</td>
<td>
123 (54.9%)
</td>
<td>
117 (40.2%)
</td>
<td>
</td>
</tr>
<tr>
<td>
T\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.033
</td>
</tr>
<tr>
<td>
    pT1
</td>
<td>
21 ( 9.5%)
</td>
<td>
36 (12.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT2
</td>
<td>
93 (41.9%)
</td>
<td>
109 (37.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT3
</td>
<td>
90 (40.5%)
</td>
<td>
101 (34.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT4
</td>
<td>
18 ( 8.1%)
</td>
<td>
46 (15.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
N\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.184
</td>
</tr>
<tr>
<td>
    N0
</td>
<td>
119 (55.1%)
</td>
<td>
178 (61.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    N1-2
</td>
<td>
97 (44.9%)
</td>
<td>
112 (38.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
M\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.015
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
200 (91.7%)
</td>
<td>
244 (84.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
18 ( 8.3%)
</td>
<td>
46 (15.9%)
</td>
<td>
</td>
</tr>
<tr>
<td>
AJCC.stage
</td>
<td>
</td>
<td>
</td>
<td>
0.032
</td>
</tr>
<tr>
<td>
    I
</td>
<td>
21 ( 9.4%)
</td>
<td>
36 (12.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    II
</td>
<td>
98 (43.9%)
</td>
<td>
112 (38.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    III
</td>
<td>
86 (38.6%)
</td>
<td>
98 (33.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    IV
</td>
<td>
18 ( 8.1%)
</td>
<td>
46 (15.8%)
</td>
<td>
</td>
</tr>
<tr>
<td>
p53mutated
</td>
<td>
</td>
<td>
</td>
<td>
0.771
</td>
</tr>
<tr>
<td>
    Wt
</td>
<td>
93 (41.3%)
</td>
<td>
126 (43.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    mutated
</td>
<td>
132 (58.7%)
</td>
<td>
167 (57.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
MSI\_Status\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    MSS
</td>
<td>
122 (54.2%)
</td>
<td>
212 (72.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    MSI-H
</td>
<td>
62 (27.6%)
</td>
<td>
66 (22.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    MSI-L
</td>
<td>
41 (18.2%)
</td>
<td>
15 ( 5.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
decade
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    1981-1990
</td>
<td>
63 (28.0%)
</td>
<td>
120 (41.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1991-2000
</td>
<td>
69 (30.7%)
</td>
<td>
113 (38.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    2001-2007
</td>
<td>
93 (41.3%)
</td>
<td>
60 (20.5%)
</td>
<td>
</td>
</tr>
<tr>
<td>
event
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
166 (73.8%)
</td>
<td>
156 (53.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
59 (26.2%)
</td>
<td>
135 (46.4%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Survival\_V
</td>
<td>
62.7 ± 59.5
</td>
<td>
69.7 ± 67.0
</td>
<td>
0.225
</td>
</tr>
</table>
Table 2a. Does MSI influence association within race?
-----------------------------------------------------

<table>
<colgroup>
<col width="10%" />
<col width="89%" />
</colgroup>
<thead>
<tr class="header">
<th>Race</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Blacks</td>
<td>MSI-L are older</td>
</tr>
<tr class="even">
<td>Whites</td>
<td>MSI-H and MSI-L are majority proximal, P53 mutations in majority of MIS-L, MSS</td>
</tr>
</tbody>
</table>

<head>
<style>
        table, th, td {
        border: 1px solid #bcbcbc;
    } </style>
</head>
<table cellpadding="5" cellspacing="5">
<caption>
Descriptive Statistics stratified by Race\_V and MSI\_Status\_V
</caption>
<tr>
<th>
Race\_V
</th>
<th colspan="4">
Black
</th>
<th colspan="4">
White
</th>
</tr>
<tr>
<th>
MSI\_Status\_V
</th>
<th>
MSS<br/>(N=122)
</th>
<th>
MSI-H<br/>(N=62)
</th>
<th>
MSI-L<br/>(N=41)
</th>
<th>
p
</th>
<th>
MSS<br/>(N=212)
</th>
<th>
MSI-H<br/>(N=66)
</th>
<th>
MSI-L<br/>(N=15)
</th>
<th>
p
</th>
</tr>
<tr>
<td>
AGE\_MB
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.016
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.982
</td>
</tr>
<tr>
<td>
    ? 65
</td>
<td>
72 (59.0%)
</td>
<td>
29 (46.8%)
</td>
<td>
14 (34.1%)
</td>
<td>
</td>
<td>
108 (50.9%)
</td>
<td>
34 (51.5%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    &lt; 65
</td>
<td>
50 (41.0%)
</td>
<td>
33 (53.2%)
</td>
<td>
27 (65.9%)
</td>
<td>
</td>
<td>
104 (49.1%)
</td>
<td>
32 (48.5%)
</td>
<td>
7 (46.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Sex\_V
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.543
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.934
</td>
</tr>
<tr>
<td>
    F
</td>
<td>
65 (53.3%)
</td>
<td>
31 (50.0%)
</td>
<td>
25 (61.0%)
</td>
<td>
</td>
<td>
72 (34.0%)
</td>
<td>
24 (36.4%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    M
</td>
<td>
57 (46.7%)
</td>
<td>
31 (50.0%)
</td>
<td>
16 (39.0%)
</td>
<td>
</td>
<td>
140 (66.0%)
</td>
<td>
42 (63.6%)
</td>
<td>
10 (66.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Location\_MB
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.608
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.024
</td>
</tr>
<tr>
<td>
    Rectum
</td>
<td>
14 (11.5%)
</td>
<td>
6 ( 9.7%)
</td>
<td>
4 (10.0%)
</td>
<td>
</td>
<td>
64 (30.2%)
</td>
<td>
11 (16.9%)
</td>
<td>
4 (28.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Distal
</td>
<td>
46 (37.7%)
</td>
<td>
21 (33.9%)
</td>
<td>
10 (25.0%)
</td>
<td>
</td>
<td>
73 (34.4%)
</td>
<td>
21 (32.3%)
</td>
<td>
1 ( 7.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Proximal
</td>
<td>
62 (50.8%)
</td>
<td>
35 (56.5%)
</td>
<td>
26 (65.0%)
</td>
<td>
</td>
<td>
75 (35.4%)
</td>
<td>
33 (50.8%)
</td>
<td>
9 (64.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
T\_MB
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.444
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.098
</td>
</tr>
<tr>
<td>
    pT1
</td>
<td>
12 ( 9.9%)
</td>
<td>
6 (10.0%)
</td>
<td>
3 ( 7.3%)
</td>
<td>
</td>
<td>
24 (11.4%)
</td>
<td>
11 (16.7%)
</td>
<td>
1 ( 6.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT2
</td>
<td>
47 (38.8%)
</td>
<td>
28 (46.7%)
</td>
<td>
18 (43.9%)
</td>
<td>
</td>
<td>
76 (36.0%)
</td>
<td>
25 (37.9%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT3
</td>
<td>
48 (39.7%)
</td>
<td>
25 (41.7%)
</td>
<td>
17 (41.5%)
</td>
<td>
</td>
<td>
83 (39.3%)
</td>
<td>
15 (22.7%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT4
</td>
<td>
14 (11.6%)
</td>
<td>
1 ( 1.7%)
</td>
<td>
3 ( 7.3%)
</td>
<td>
</td>
<td>
28 (13.3%)
</td>
<td>
15 (22.7%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
N\_MB
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.136
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.880
</td>
</tr>
<tr>
<td>
    N0
</td>
<td>
60 (50.0%)
</td>
<td>
37 (66.1%)
</td>
<td>
22 (55.0%)
</td>
<td>
</td>
<td>
128 (60.7%)
</td>
<td>
40 (62.5%)
</td>
<td>
10 (66.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    N1-2
</td>
<td>
60 (50.0%)
</td>
<td>
19 (33.9%)
</td>
<td>
18 (45.0%)
</td>
<td>
</td>
<td>
83 (39.3%)
</td>
<td>
24 (37.5%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
M\_V
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.077
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.058
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
106 (88.3%)
</td>
<td>
57 (98.3%)
</td>
<td>
37 (92.5%)
</td>
<td>
</td>
<td>
184 (87.2%)
</td>
<td>
48 (75.0%)
</td>
<td>
12 (80.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
14 (11.7%)
</td>
<td>
1 ( 1.7%)
</td>
<td>
3 ( 7.5%)
</td>
<td>
</td>
<td>
27 (12.8%)
</td>
<td>
16 (25.0%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
AJCC.stage
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.374
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.059
</td>
</tr>
<tr>
<td>
    I
</td>
<td>
12 ( 9.9%)
</td>
<td>
6 ( 9.8%)
</td>
<td>
3 ( 7.3%)
</td>
<td>
</td>
<td>
24 (11.4%)
</td>
<td>
11 (16.7%)
</td>
<td>
1 ( 6.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    II
</td>
<td>
48 (39.7%)
</td>
<td>
31 (50.8%)
</td>
<td>
19 (46.3%)
</td>
<td>
</td>
<td>
79 (37.4%)
</td>
<td>
25 (37.9%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    III
</td>
<td>
47 (38.8%)
</td>
<td>
23 (37.7%)
</td>
<td>
16 (39.0%)
</td>
<td>
</td>
<td>
81 (38.4%)
</td>
<td>
14 (21.2%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    IV
</td>
<td>
14 (11.6%)
</td>
<td>
1 ( 1.6%)
</td>
<td>
3 ( 7.3%)
</td>
<td>
</td>
<td>
27 (12.8%)
</td>
<td>
16 (24.2%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
p53mutated
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.263
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
</tr>
<tr>
<td>
    Wt
</td>
<td>
46 (37.7%)
</td>
<td>
31 (50.0%)
</td>
<td>
16 (39.0%)
</td>
<td>
</td>
<td>
83 (39.2%)
</td>
<td>
41 (62.1%)
</td>
<td>
2 (13.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    mutated
</td>
<td>
76 (62.3%)
</td>
<td>
31 (50.0%)
</td>
<td>
25 (61.0%)
</td>
<td>
</td>
<td>
129 (60.8%)
</td>
<td>
25 (37.9%)
</td>
<td>
13 (86.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
decade
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.314
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.401
</td>
</tr>
<tr>
<td>
    1981-1990
</td>
<td>
36 (29.5%)
</td>
<td>
19 (30.6%)
</td>
<td>
8 (19.5%)
</td>
<td>
</td>
<td>
84 (39.6%)
</td>
<td>
32 (48.5%)
</td>
<td>
4 (26.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1991-2000
</td>
<td>
42 (34.4%)
</td>
<td>
15 (24.2%)
</td>
<td>
12 (29.3%)
</td>
<td>
</td>
<td>
86 (40.6%)
</td>
<td>
21 (31.8%)
</td>
<td>
6 (40.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    2001-2007
</td>
<td>
44 (36.1%)
</td>
<td>
28 (45.2%)
</td>
<td>
21 (51.2%)
</td>
<td>
</td>
<td>
42 (19.8%)
</td>
<td>
13 (19.7%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
event
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.026
</td>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
0.538
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
82 (67.2%)
</td>
<td>
48 (77.4%)
</td>
<td>
36 (87.8%)
</td>
<td>
</td>
<td>
115 (54.8%)
</td>
<td>
35 (53.0%)
</td>
<td>
6 (40.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
40 (32.8%)
</td>
<td>
14 (22.6%)
</td>
<td>
5 (12.2%)
</td>
<td>
</td>
<td>
95 (45.2%)
</td>
<td>
31 (47.0%)
</td>
<td>
9 (60.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Survival\_V
</td>
<td>
66.9 ± 63.0
</td>
<td>
52.7 ± 50.2
</td>
<td>
65.3 ± 61.2
</td>
<td>
0.305
</td>
<td>
71.1 ± 67.8
</td>
<td>
70.5 ± 70.0
</td>
<td>
46.8 ± 31.6
</td>
<td>
0.397
</td>
</tr>
</table>
Table 2b. Does race influence association within MSI?
-----------------------------------------------------

<table>
<colgroup>
<col width="14%" />
<col width="86%" />
</colgroup>
<thead>
<tr class="header">
<th>MSS status</th>
<th>Observation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>MSS</td>
<td>More white males,more black proximals, less whites diagnosed in recent decade</td>
</tr>
<tr class="even">
<td>MSI-H</td>
<td>Few late stage blacks, more metastasis in whites, half of whites diagnosed 1981-1990</td>
</tr>
<tr class="odd">
<td>MSI-L</td>
<td>borderline more p53 mutation in whites</td>
</tr>
</tbody>
</table>

<head>
<style>
        table, th, td {
        border: 1px solid #bcbcbc;
    } </style>
</head>
<table cellpadding="5" cellspacing="5">
<caption>
Descriptive Statistics stratified by MSI\_Status\_V and Race\_V
</caption>
<tr>
<th>
MSI\_Status\_V
</th>
<th colspan="3">
MSS
</th>
<th colspan="3">
MSI-H
</th>
<th colspan="3">
MSI-L
</th>
</tr>
<tr>
<th>
Race\_V
</th>
<th>
Black<br/>(N=122)
</th>
<th>
White<br/>(N=212)
</th>
<th>
p
</th>
<th>
Black<br/>(N=62)
</th>
<th>
White<br/>(N=66)
</th>
<th>
p
</th>
<th>
Black<br/>(N=41)
</th>
<th>
White<br/>(N=15)
</th>
<th>
p
</th>
</tr>
<tr>
<td>
AGE\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.190
</td>
<td>
</td>
<td>
</td>
<td>
0.719
</td>
<td>
</td>
<td>
</td>
<td>
0.321
</td>
</tr>
<tr>
<td>
    ? 65
</td>
<td>
72 (59.0%)
</td>
<td>
108 (50.9%)
</td>
<td>
</td>
<td>
29 (46.8%)
</td>
<td>
34 (51.5%)
</td>
<td>
</td>
<td>
14 (34.1%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    &lt; 65
</td>
<td>
50 (41.0%)
</td>
<td>
104 (49.1%)
</td>
<td>
</td>
<td>
33 (53.2%)
</td>
<td>
32 (48.5%)
</td>
<td>
</td>
<td>
27 (65.9%)
</td>
<td>
7 (46.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Sex\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.001
</td>
<td>
</td>
<td>
</td>
<td>
0.168
</td>
<td>
</td>
<td>
</td>
<td>
0.125
</td>
</tr>
<tr>
<td>
    F
</td>
<td>
65 (53.3%)
</td>
<td>
72 (34.0%)
</td>
<td>
</td>
<td>
31 (50.0%)
</td>
<td>
24 (36.4%)
</td>
<td>
</td>
<td>
25 (61.0%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    M
</td>
<td>
57 (46.7%)
</td>
<td>
140 (66.0%)
</td>
<td>
</td>
<td>
31 (50.0%)
</td>
<td>
42 (63.6%)
</td>
<td>
</td>
<td>
16 (39.0%)
</td>
<td>
10 (66.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Location\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.000
</td>
<td>
</td>
<td>
</td>
<td>
0.482
</td>
<td>
</td>
<td>
</td>
<td>
0.133
</td>
</tr>
<tr>
<td>
    Rectum
</td>
<td>
14 (11.5%)
</td>
<td>
64 (30.2%)
</td>
<td>
</td>
<td>
6 ( 9.7%)
</td>
<td>
11 (16.9%)
</td>
<td>
</td>
<td>
4 (10.0%)
</td>
<td>
4 (28.6%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Distal
</td>
<td>
46 (37.7%)
</td>
<td>
73 (34.4%)
</td>
<td>
</td>
<td>
21 (33.9%)
</td>
<td>
21 (32.3%)
</td>
<td>
</td>
<td>
10 (25.0%)
</td>
<td>
1 ( 7.1%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    Proximal
</td>
<td>
62 (50.8%)
</td>
<td>
75 (35.4%)
</td>
<td>
</td>
<td>
35 (56.5%)
</td>
<td>
33 (50.8%)
</td>
<td>
</td>
<td>
26 (65.0%)
</td>
<td>
9 (64.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
T\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.920
</td>
<td>
</td>
<td>
</td>
<td>
0.001
</td>
<td>
</td>
<td>
</td>
<td>
0.350
</td>
</tr>
<tr>
<td>
    pT1
</td>
<td>
12 ( 9.9%)
</td>
<td>
24 (11.4%)
</td>
<td>
</td>
<td>
6 (10.0%)
</td>
<td>
11 (16.7%)
</td>
<td>
</td>
<td>
3 ( 7.3%)
</td>
<td>
1 ( 6.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT2
</td>
<td>
47 (38.8%)
</td>
<td>
76 (36.0%)
</td>
<td>
</td>
<td>
28 (46.7%)
</td>
<td>
25 (37.9%)
</td>
<td>
</td>
<td>
18 (43.9%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT3
</td>
<td>
48 (39.7%)
</td>
<td>
83 (39.3%)
</td>
<td>
</td>
<td>
25 (41.7%)
</td>
<td>
15 (22.7%)
</td>
<td>
</td>
<td>
17 (41.5%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    pT4
</td>
<td>
14 (11.6%)
</td>
<td>
28 (13.3%)
</td>
<td>
</td>
<td>
1 ( 1.7%)
</td>
<td>
15 (22.7%)
</td>
<td>
</td>
<td>
3 ( 7.3%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
N\_MB
</td>
<td>
</td>
<td>
</td>
<td>
0.077
</td>
<td>
</td>
<td>
</td>
<td>
0.829
</td>
<td>
</td>
<td>
</td>
<td>
0.635
</td>
</tr>
<tr>
<td>
    N0
</td>
<td>
60 (50.0%)
</td>
<td>
128 (60.7%)
</td>
<td>
</td>
<td>
37 (66.1%)
</td>
<td>
40 (62.5%)
</td>
<td>
</td>
<td>
22 (55.0%)
</td>
<td>
10 (66.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    N1-2
</td>
<td>
60 (50.0%)
</td>
<td>
83 (39.3%)
</td>
<td>
</td>
<td>
19 (33.9%)
</td>
<td>
24 (37.5%)
</td>
<td>
</td>
<td>
18 (45.0%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
M\_V
</td>
<td>
</td>
<td>
</td>
<td>
0.899
</td>
<td>
</td>
<td>
</td>
<td>
0.001
</td>
<td>
</td>
<td>
</td>
<td>
0.402
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
106 (88.3%)
</td>
<td>
184 (87.2%)
</td>
<td>
</td>
<td>
57 (98.3%)
</td>
<td>
48 (75.0%)
</td>
<td>
</td>
<td>
37 (92.5%)
</td>
<td>
12 (80.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
14 (11.7%)
</td>
<td>
27 (12.8%)
</td>
<td>
</td>
<td>
1 ( 1.7%)
</td>
<td>
16 (25.0%)
</td>
<td>
</td>
<td>
3 ( 7.5%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
AJCC.stage
</td>
<td>
</td>
<td>
</td>
<td>
0.951
</td>
<td>
</td>
<td>
</td>
<td>
0.001
</td>
<td>
</td>
<td>
</td>
<td>
0.401
</td>
</tr>
<tr>
<td>
    I
</td>
<td>
12 ( 9.9%)
</td>
<td>
24 (11.4%)
</td>
<td>
</td>
<td>
6 ( 9.8%)
</td>
<td>
11 (16.7%)
</td>
<td>
</td>
<td>
3 ( 7.3%)
</td>
<td>
1 ( 6.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    II
</td>
<td>
48 (39.7%)
</td>
<td>
79 (37.4%)
</td>
<td>
</td>
<td>
31 (50.8%)
</td>
<td>
25 (37.9%)
</td>
<td>
</td>
<td>
19 (46.3%)
</td>
<td>
8 (53.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    III
</td>
<td>
47 (38.8%)
</td>
<td>
81 (38.4%)
</td>
<td>
</td>
<td>
23 (37.7%)
</td>
<td>
14 (21.2%)
</td>
<td>
</td>
<td>
16 (39.0%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    IV
</td>
<td>
14 (11.6%)
</td>
<td>
27 (12.8%)
</td>
<td>
</td>
<td>
1 ( 1.6%)
</td>
<td>
16 (24.2%)
</td>
<td>
</td>
<td>
3 ( 7.3%)
</td>
<td>
3 (20.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
p53mutated
</td>
<td>
</td>
<td>
</td>
<td>
0.885
</td>
<td>
</td>
<td>
</td>
<td>
0.229
</td>
<td>
</td>
<td>
</td>
<td>
0.134
</td>
</tr>
<tr>
<td>
    Wt
</td>
<td>
46 (37.7%)
</td>
<td>
83 (39.2%)
</td>
<td>
</td>
<td>
31 (50.0%)
</td>
<td>
41 (62.1%)
</td>
<td>
</td>
<td>
16 (39.0%)
</td>
<td>
2 (13.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    mutated
</td>
<td>
76 (62.3%)
</td>
<td>
129 (60.8%)
</td>
<td>
</td>
<td>
31 (50.0%)
</td>
<td>
25 (37.9%)
</td>
<td>
</td>
<td>
25 (61.0%)
</td>
<td>
13 (86.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
decade
</td>
<td>
</td>
<td>
</td>
<td>
0.004
</td>
<td>
</td>
<td>
</td>
<td>
0.008
</td>
<td>
</td>
<td>
</td>
<td>
0.493
</td>
</tr>
<tr>
<td>
    1981-1990
</td>
<td>
36 (29.5%)
</td>
<td>
84 (39.6%)
</td>
<td>
</td>
<td>
19 (30.6%)
</td>
<td>
32 (48.5%)
</td>
<td>
</td>
<td>
8 (19.5%)
</td>
<td>
4 (26.7%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1991-2000
</td>
<td>
42 (34.4%)
</td>
<td>
86 (40.6%)
</td>
<td>
</td>
<td>
15 (24.2%)
</td>
<td>
21 (31.8%)
</td>
<td>
</td>
<td>
12 (29.3%)
</td>
<td>
6 (40.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    2001-2007
</td>
<td>
44 (36.1%)
</td>
<td>
42 (19.8%)
</td>
<td>
</td>
<td>
28 (45.2%)
</td>
<td>
13 (19.7%)
</td>
<td>
</td>
<td>
21 (51.2%)
</td>
<td>
5 (33.3%)
</td>
<td>
</td>
</tr>
<tr>
<td>
event
</td>
<td>
</td>
<td>
</td>
<td>
0.035
</td>
<td>
</td>
<td>
</td>
<td>
0.007
</td>
<td>
</td>
<td>
</td>
<td>
0.001
</td>
</tr>
<tr>
<td>
    0
</td>
<td>
82 (67.2%)
</td>
<td>
115 (54.8%)
</td>
<td>
</td>
<td>
48 (77.4%)
</td>
<td>
35 (53.0%)
</td>
<td>
</td>
<td>
36 (87.8%)
</td>
<td>
6 (40.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
    1
</td>
<td>
40 (32.8%)
</td>
<td>
95 (45.2%)
</td>
<td>
</td>
<td>
14 (22.6%)
</td>
<td>
31 (47.0%)
</td>
<td>
</td>
<td>
5 (12.2%)
</td>
<td>
9 (60.0%)
</td>
<td>
</td>
</tr>
<tr>
<td>
Survival\_V
</td>
<td>
66.9 ± 63.0
</td>
<td>
71.1 ± 67.8
</td>
<td>
0.590
</td>
<td>
52.7 ± 50.2
</td>
<td>
70.5 ± 70.0
</td>
<td>
0.103
</td>
<td>
65.3 ± 61.2
</td>
<td>
46.8 ± 31.6
</td>
<td>
0.147
</td>
</tr>
</table>
Note that survival by race is a major issue in this study
---------------------------------------------------------

`Figure 1` shows unadjusted KM survival with whites having a significantly quicker time to death from cancer than blacks ![](MSI_2_files/figure-markdown_github/KM1-1.png)

This is consistant across MSI Status.
-------------------------------------

![](MSI_2_files/figure-markdown_github/KM2-1.png)

Note survival by MSI by comparison
----------------------------------

![](MSI_2_files/figure-markdown_github/KM3-1.png)

Then race stratified MSI survival
---------------------------------

![](MSI_2_files/figure-markdown_github/KM4-1.png)
